These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8938949)

  • 1. Bcl-2 oncoprotein expression is increased especially in the portion of small cell carcinoma within the combined type of small cell lung cancer.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
    Tumour Biol; 1996; 17(6):341-4. PubMed ID: 8938949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
    Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Nakamori S; Tateishi R
    J Surg Oncol; 1997 Jan; 64(1):48-54. PubMed ID: 9040801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
    Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
    LaPoint RJ; Bourne PA; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
    Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2--protein in small cell lung cancer.
    Kaiser U; Schilli M; Haag U; Neumann K; Kreipe H; Kogan E; Havemann K
    Lung Cancer; 1996 Aug; 15(1):31-40. PubMed ID: 8865121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemistry of biomolecular markers of lung cancer].
    Kogan EA; Zhak G; Kaĭzer U; Shilli M; Shurman M; Sherer A; Khavemann K
    Arkh Patol; 1997; 59(6):23-30. PubMed ID: 9483214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bcl-2 in small cell lung carcinoma cells.
    Ikegaki N; Katsumata M; Minna J; Tsujimoto Y
    Cancer Res; 1994 Jan; 54(1):6-8. PubMed ID: 8261463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status.
    Dosaka-Akita H; Katabami M; Hommura H; Fujioka Y; Katoh H; Kawakami Y
    Oncology; 1999 Apr; 56(3):259-64. PubMed ID: 10202283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical markers of prolonged survival in small cell carcinoma of the lung. An immunohistochemical study.
    Sloman A; D'Amico F; Yousem SA
    Arch Pathol Lab Med; 1996 May; 120(5):465-72. PubMed ID: 8639050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma.
    Eymin B; Gazzeri S; Brambilla C; Brambilla E
    Oncogene; 2001 Mar; 20(14):1678-87. PubMed ID: 11313916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in small cell lung carcinoma is independent of Bcl-2 expression.
    Maitra A; Amirkhan RH; Saboorian MH; Frawley WH; Ashfaq R
    Hum Pathol; 1999 Jun; 30(6):712-7. PubMed ID: 10374782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
    Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
    Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 immunostaining in combined type small cell lung cancer. Brief report.
    Higashiyama M; Doi O; Yokouchi H; Kodama K; Tateishi R
    APMIS; 1995 Jun; 103(6):477-80. PubMed ID: 7546652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
    Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
    Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
    Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer.
    Lee HW; Han JH; Kim JH; Lee MH; Jeong SH; Kang SY; Choi JH; Oh YT; Park KJ; Hwang SC; Sheen SS; Lim HY
    Lung Cancer; 2008 Jan; 59(1):95-104. PubMed ID: 17889401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.